Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
About this study
The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.
- Condition
- Diabetes Type 2
- Tested
- Dulce Digital Text Messaging Intervention, CGM Device
- Sponsor
- Scripps Whittier Diabetes Institute
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 8
- Minimum age: 18 years
- Study condition: Diabetes Type 2
- Diagnosed with type 2 diabetes
- Are not currently using a CGM
- Are not using insulin therapies
- Speak English, Spanish or Arabic
- Have A1c between 7.5% and 12.0% in last 90 days
- Have a cellphone that can receive/send text messages and counts steps
Exclusion 4
- Are using insulin therapies
- Are pregnant
- Are currently using a CGM
- Are currently participating in another diabetes-related study
Where
1 site, 1 recruiting
Scripps Whittier Diabetes Institute
San Diego, California, United States
Contact
-
Kallie Brown, PhD
858-258-3555 brown.kallie@scrippshealth.org
-
Athena Philis-Tsimikas, MD
877-944-8843 philis-Tsimikas.athena@scrippshealth.org
Potential match only. Final eligibility is determined by the study team.